CIBC Private Wealth Group
ROIV icon

CIBC Private Wealth Group’s Roivant Sciences ROIV Stock Holding History

CIBC Private Wealth Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$58.6K Buy
2,700
+2,665
+7,614% +$52.6K ﹤0.01% 1720
2025
Q3 		$530 Hold
35
– – ﹤0.01% 2883
2025
Q2 		$394 Sell
35
-2,065
-98% -$22.4K ﹤0.01% 2864
2025
Q1 		$19.1K Buy
2,100
+2,000
+2,000% +$21.6K ﹤0.01% 2010
2024
Q4 		$1.1K Hold
100
– – ﹤0.01% 2783
2024
Q3 		$1.15K Hold
100
– – ﹤0.01% 2894
2024
Q2 		$1.07K Hold
100
– – ﹤0.01% 2891
2024
Q1 		$1.04K Buy
+100
New +$1.08K ﹤0.01% 2853

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CIBC Private Wealth Group's ROIV Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Roivant Sciences (ROIV) stake by 7,614% in Q4 2025, buying an estimated $52.6K and bringing the position to 2,700 shares worth $58.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

CIBC Private Wealth Group first reported a position in ROIV in Q1 2024 and has held it in 8 quarters since. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • CIBC Private Wealth Group held 2,700 shares of Roivant Sciences worth $58.6K as of Q4 2025.
  • CIBC Private Wealth Group bought 2,665 Roivant Sciences shares in Q4 2025, an estimated $52.6K.
  • Roivant Sciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1720 holding.
  • CIBC Private Wealth Group first reported a position in Roivant Sciences in Q1 2024 and has held it in 8 quarters since.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.